EU Message: This test is not available to persons established in the EU.
Decode the Pathways Driving Metabolic Health
DNA Signature – MetabolicPath evaluates foundational genomic variations governing cellular energy production, nutrient utilization, neurotransmitter balance, gut health, methylation/detoxification, and nutrient needs. By assessing interconnected physiological pathways rather than isolated variants, it provides a comprehensive blueprint of baseline biochemistry to help practitioners uncover potential underlying drivers of persistent functional imbalances.
Even when standard biomarkers appear within normal reference ranges, subtle genetic variations can significantly alter metabolic throughput. DNA Signature – MetabolicPath bridges this gap, translating complex genetic data into an actionable strategy for targeted nutrient, dietary, lifestyle, and testing protocols.
Designed as the genetic companion to the MosaicDX Organic Acids Test (OAT).
Why Use the DNA Signature – Metabolic Path Profile?
DNA Signature – Metabolic evaluates the foundational genetic variations that govern cellular energy production, nutrient metabolism, neurotransmitter balance, and systemic resilience. By assessing interconnected physiological pathways rather than isolated variants, this panel provides a comprehensive blueprint of a patient’s baseline biochemistry, helping practitioners uncover potential underlying drivers of persistent functional imbalances.
Core Functional Domains Evaluated
Nutrient Utilization & Cofactor Requirements
B-Vitamin Dynamics: Maps functional processing and utilization tendencies for key B vitamins, essential co-factors for things like mitochondrial function, gut health, detoxification, methylation and neurotransmitter synthesis and breakdown.
Essential Mineral Status: Identifies genetic predisposition to depletion of essential minerals like Iron and Magnesium.
Antioxidant & Micronutrient Propensity: Evaluates genetic tendencies toward challenges with absorbing and utilizing key antioxidants like vitamin C, vitamin D, and CoQ10.
Methylation & Neuro-Metabolic Balance
Methylation: Assesses core drivers of methylation pathways, including MTHFR, MTR, and MTRR, which support DNA repair, detoxification, and cellular regeneration.
Neuro-Chemical Regulation: Evaluates COMT activity (methylation) and GAD1 activity to understand neurotransmitter turnover, catecholamine clearance, and GABA synthesis.
Neuro-Behavioral Tendencies: Maps genetic associations related to anxiety, depression, rumination, and OCD behaviors.
Stress Adaptation: Identifies individual Stress Phenotypes and biological Stress Adaptation capacity to explain distinct thresholds for physical and psychological stress.
Cellular Energy, Defense & Tissue Integrity
Mitochondrial Output & Stamina: Evaluates mitochondrial function and CoQ10 production pathways driving cellular ATP generation.
Oxidative Defense & Detoxification: Assesses SNPs impacting endogenous glutathione levels, overall Phase II Detox efficiency, and capacity to buffer against oxidative stress.
Barrier Function & Environmental Sensitivity: Pinpoints genetic susceptibility to gut permeability and heightened mold sensitivity.
Our high-complexity laboratory is committed to delivering accurate and reliable results in coordination with these top licensure programs:
Analytes
From a single easy-to-collect buccal swab you will receive a personalized polygenic risk score for the following traits:
MTHFR Activity
MTR
MTRR
COMT (Methylation)
Phase II Detox Efficiency
Vitamin B12
Vitamin B6
Vitamin B9 (Folate)
Vitamin C Propensity
Vitamin D Deficiency Risk
Iron Deficiency Risk
Magnesium Deficiency Risk
CoQ10
Glutathione
Anxiety Propensity
Depression Propensity
GAD1 Activity
OCD Likelihood
Rumination
Stress Adaptation
Stress Phenotype
Gut Permeability
Mold Sensitivity
Oxidative Stress
Mitochondrial Function
Sample Reports
The DNA Methylation Profile report aids clinical support for patients by pinpointing SNPs that could potentially impact health and disease risk.
MosaicDX offers patient-friendly sample collection kits that simplify testing. Our kits include visual, step-by-step instructions for test preparation and sample collection, personalized shipping cards, and pediatric collection bags if needed. With MosaicDX, patients can easily collect samples for testing with confidence and accuracy.
No, we do not. A genetic carrier refers to an individual who has inherited a recessive allele that has been shown to be responsible for an autosomal recessive disease or trait. A genetic carrier only has one recessive allele so while they do not show signs or symptoms of the trait or disease, they are able to pass along the recessive gene to their child. Our genetic testing is for screening purposes only to assess risk or predisposition for certain traits associated with health and wellness.
No. We do not use patient samples for further research or testing. We may use your de-identified and anonymized data to help improve our algorithm and reports. Your data will not be sold or shared to or with any 3rd parties/commercial interests.
Yes, we can delete the patient’s raw genetic sequence at any time. Please note that applicable federal and state laws require us to retain your patient report and the subset of your data that was used to generate that report for a specified period of time. We will be happy to delete any and all of your data that we are legally allowed to delete upon request. Please submit your request here.
We implement rigorous selection criteria when choosing which genes or SNPs to include in our panels. The selection and validation criteria are based upon peer-reviewed studies that show a significant association between the SNP variant and trait or condition, the magnitude of the odds ratio (OR) or hazard ratio (HR) to assess risk related to the variant, as well as the population or populations the gene and SNP variant were studied in, the population size, and replication of findings.
A genotype refers to the actual inherited genetic material of an individual that can influence or determine certain characteristics or traits. A phenotype is how the genotype is actually expressed, that is the observable or measurable characteristics or traits of an individual.
SNP is also called a Single Nucleotide Polymorphism. Your DNA consists of 4 main building blocks (nucleotides), Adenine (A), Thymine (T), Guanine (G), and Cytosine (C). In certain locations within your DNA, one person may have an A, whereas another may have a G. This difference in the base pair is often called a variant. This variant is an SNP.
In most situations, you do not have to resubmit a DNA buccal swab sample if you later want to order additional panels. The only time a new DNA buccal swab would need to be resubmitted is if the assay has had significant changes, or the patient previously requested that their DNA sequencing results be deleted.
Patients are sent a DNA Signature Collection Kit containing instructions, 1 cheek swab, a DNA Sample Envelope and a prepaid return envelope and biohazard zip-lock bag. Instructions can also be found on our website on the DNA Signature Profiles web page, along with an easy-to-follow video.
A person’s polygenic risk score is a statistical calculation based on the presence or absence of multiple genomic variants without taking environmental or other factors into account
Different states have regulations that define the scope of practice for practitioners. It is the practitioner’s responsibility to abide by these rules. Check with your state board of health to determine any restrictions related to laboratory testing. Please note, Mosaic Diagnostics does not offer testing in New York.
Once you have opened your account, you have the options of ordering kits to stock in your office or drop-ship kits directly to your patients through your MosaicDX portal.
Watch our short tutorial videos on how to conveniently
Du J, Zhao M, Zhang W et al. Folate and vitamin B12 status in relation to anemia, macrocytosis and cognitive impairment in older Americans. J Nutr. 2018;148(9):1447-1455. doi:10.1093/jn/nxy178. PMID: 29644956.
Colson NJ, Bhatt DL, Bhatt K et al. The impact of MTHFR 677 C/T genotypes on folate status markers: a meta-analysis of folic acid intervention studies. Eur J Nutr. 2017;56(1):247-260. doi:10.1007/s00394-015-1076-x. PMID: 26497154.
Bueno O, Molloy AM, Fernandez-Ballart JD et al. Common polymorphisms that affect folate transport or metabolism modify the effect of the MTHFR 677C>T polymorphism on folate status. J Nutr. 2016;146(1):1-8. doi:10.3945/jn.115.219907. PMID: 26561410.
Martinez Serrano J, Saus E, Llorca-Bofí V et al. The influence of Val158Met COMT on physiological stress responsivity. Stress. 2019;22(2):276-279. doi:10.1080/10253890.2018.1548540. PMID: 30628551.
Lovallo WR, Cohoon AJ, Acheson A et al. Joint impact of early life adversity and COMT Val158Met (rs4680) genotypes on the adult cortisol response to psychological stress. Psychosom Med. 2017;79(7):820-828. doi:10.1097/PSY.0000000000000483. PMID: 28525432.
van der Knaap LJ, Franken IHA, Larsen JK, Blanken P. COMT gene methylation and substance use in adolescents. Genes Brain Behav. 2014;13(7):658-64. doi:10.1111/gbb.12152. PMID: 24902721.
Kumari R, Bhatt M, Nayak C, Kaul S. MTHFR C677T and MTR A2756G gene polymorphism in neural tube defect patients. J Indian Assoc Pediatr Surg. 2022;27(6):703-708. doi:10.4103/jiaps.jiaps_207_21. PMID: 36714485.
Jacques PF, Bostom AG, Selhub J et al. Effects of polymorphisms of methionine synthase and methionine synthase reductase on total plasma homocysteine in the NHLBI Family Heart Study. Atherosclerosis. 2002;166(1):49-55. doi:10.1016/s0021-9150(02)00076-7. PMID:
Cai B, Zhu JL, Ma J et al. MTRR A66G polymorphism and risk of congenital heart disease: a meta-analysis involving 2,960 cases and 4,624 controls. PLoS ONE. 2014;9(4):e96083. doi:10.1371/journal.pone.0096083. PMID: 25463711.
Saha T, Chatterjee M, Sinha S, Rajamma U, Mukhopadhyay K. Genetic variants of folate metabolic system and mild hyperhomocysteinemia may affect ADHD. Prog Neuropsychopharmacol Biol Psychiatry. 2018;86:176-183. doi:10.1016/j.pnpbp.2018.05.017. PMID: 20852008.
Zhao Q, Shen Z, Pei G et al. CBS gene polymorphism rs2851391 and folate therapy efficacy in hyperhomocysteinemia. J Gene Med. 2020;22(1):e3157. doi:10.1002/jgm.3157. PMID: 31955470.
Cho S, Cho HJ, Lee YJ et al. MTR rs1805087, MTRR rs1801394, and MTHFD1 rs2236225 association with recurrent implantation failure. Hum Fertil. 2019;22(4):280-285. doi:10.1080/14647273.2018.1482776. PMID: 30204026.
Jung IE, da Cruz IBM, Barbisan F et al. Superoxide imbalance triggered by Val16Ala-SOD2 polymorphism increases risk of depression and psychological stress in free-living elderly. Mol Genet Genomic Med. 2019;8(2):e1080. doi:10.1002/mgg3.1080. PMID: 31891227.
Pourvali K, Abbasi M, Mottaghi A. Role of superoxide dismutase 2 gene Ala16Val polymorphism and total antioxidant capacity in diabetes and its complications. Avicenna J Med Biotechnol. 2016;8(2):48-56. PMID: 27141263.
Liu K, Zhao Q, Huang L et al. Two common functional catalase gene polymorphisms (rs1001179 and rs794316) and cancer susceptibility: evidence from 14,942 cancer cases and 43,285 controls. Oncotarget. 2016;7(39):62954-62965. doi:10.18632/oncotarget.10911.
Jimenez-Ortega RF, Bautista-Frias MP, Lopez-Victorio CJ et al. Association study between antioxidant nutrient intake and low bone mineral density with oxidative stress SNVs: GPX1 (rs1050450), SOD2 (rs4880) and CAT (rs769217). Antioxidants. 2023;12(12):2089. doi:10.3390/antiox12122089. PMID: 38136209.
Zazueta C, García-Niño WR, Buelna-Chontal M, Silva-Palacios A. Genetic variations on redox control in cardiometabolic diseases: the role of Nrf2. Antioxidants (Basel). 2022;11(4):678. doi:10.3390/antiox11040678. PMID: 35326157.
Farmohammadi A, Arab-Yarmohammadi V, Ramzanpour R. Association analysis of rs1695 and rs1138272 variations in GSTP1 gene and breast cancer susceptibility. Asian Pac J Cancer Prev. 2020;21(4):1167-1172. doi:10.31557/APJCP.2020.21.4.1167. PMID: 32334487.
PMC4616369. Exome-wide association study of UGT1A1 and UGT1A6 variants in association with serum bilirubin and hyperbilirubinemia.
Romero-Lorca A, Novillo A, Gaibar M et al. Impacts of the glucuronidase genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on tamoxifen metabolism in breast cancer patients. PLoS ONE. 2015;10(7):e0132269. doi:10.1371/journal.pone.0132269.
McDonagh EM, Boukouvala S, Aklillu E et al. PharmGKB Summary: Very Important Pharmacogene information for N-acetyltransferase 2. Pharmacogenet Genomics. 2014;24(8):409-425. doi:10.1097/FPC.0000000000000062. PMID: 24892773.
Hashibe M, McKay JD, Curado MP et al. Multiple ADH genes are associated with upper aerodigestive cancers. Nat Genet. 2008;40(6):707-714. doi:10.1038/ng.151. PMID: 18948376.
Kiyohara C, Yoshimasu K, Takayama K, Nakanishi Y. GSTM1, GSTT1, and NAT2 polymorphisms and the risk of lung cancer: a HuGE review. Genet Med. 2002;4(4):227-40. PMID: 12172390.
Hashibe M, Brennan P, Chuang SC et al. Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev. 2009;18(2):541-50.
Schmuck EM, Board PG, Whitbread AK et al. Characterization of the monomethylarsonate reductase and dehydroascorbate reductase activities of Omega class glutathione transferase variants. Biochemistry. 2005;44(27):9452-62. doi:10.1021/bi050431b. PMID: 15970797.
Lo YL, Hsiao CF, Jou YS et al. Arsenic methylation, GSTO1 polymorphisms, and metabolic syndrome in an arseniasis endemic area of southwestern Taiwan. PLoS ONE. 2012;7(3):e33503. doi:10.1371/journal.pone.0033503. PMID: 22440634.
Eslami S, Sahebkar A, Mobarhan MG et al. Association of GSTO1 A140D and GSTO2 N142D gene variations with breast cancer risk. Pathol Oncol Res. 2017;23(4):797-802. doi:10.1007/s12253-016-0153-7. PMID: 28670895.
Braun N, Fendt L, Eberle M et al. GSTA1*-69C/T and GSTO2*N142D as asthma- and allergy-related risk factors in Italian adult patients. Allergy. 2014;69(4):522-30. doi:10.1111/all.12344. PMID: 24471578.
Medina Perez OM, Grillo LF, Bonotto RM et al. Glutathione-related genetic polymorphisms associated with mercury retention and nephrotoxicity in gold-mining settings. Sci Rep. 2021;11:8716. doi:10.1038/s41598-021-88137-3.
Takahashi M, Imai J, Kodama Y et al. CYP7A1, NPC1L1, ABCB1, and CD36 polymorphisms are associated with increased serum coenzyme Q10 after long-term supplementation in women. Antioxidants. 2021;10(3):431. doi:10.3390/antiox10030431.
Takahashi M, Imai J, Kodama Y et al. CYP7A1, NPC1L1, ABCB1, and CD36 polymorphisms associated with CoQ10 availability affect SF-36 quality-of-life after long-term CoQ10 supplementation. Nutrients. 2022;14(13):2579. doi:10.3390/nu14132579.
Cao X, Huang M, Li Z et al. TRPM6 and TRPM7 genetic polymorphisms, dietary magnesium, plasma magnesium, and gestational diabetes mellitus. J Nutr Biochem. 2025. doi:10.1016/j.jnutbio.2025.110067.
Corre T, Arjona FJ, Hayward C et al. Genome-wide meta-analysis unravels interactions between magnesium homeostasis and metabolic phenotypes. J Am Soc Nephrol. 2018;29(1):335-348. doi:10.1681/ASN.2017030267. PMID: 29093028.
Ji Y, Skierka JM, Blommel JH et al. Genetic factors associated with iron storage in Australian blood donors. Blood Transfus. 2018;16(2):123-129. doi:10.2450/2017.0094-17. PMID: 28151393.
Bosch ES, Sporri J, Scherr J. Genetic variants affecting iron metabolism in healthy adults: a systematic review. Nutrients. 2024;16(22):3793. doi:10.3390/nu16223793. PMID: 39599580.
Moura SS, de Souza MR, Cardoso LM et al. Vitamin D deficiency and VDR gene polymorphism FokI (rs2228570) are associated with diabetes mellitus. Diabetol Metab Syndr. 2024;16(1):118. doi:10.1186/s13098-024-01355-9. PMID: 38812030.
Revez JA, Lin T, Qiao Z et al. Genome-wide association study identifies 143 loci associated with 25 hydroxyvitamin D concentration. Nat Commun. 2020;11(1):1647. doi:10.1038/s41467-020-15421-7. PMID: 32242144.
Ji Y, Ge W, Feng X et al. GC gene polymorphisms and vitamin D binding protein levels. Nutrients. 2019. PMID: 31365099.
Duell EJ, Crous-Bou M, Sala N et al. Vitamin C transporter gene (SLC23A1 and SLC23A2) polymorphisms, plasma vitamin C levels, and gastric cancer risk in the EPIC cohort. Genes Nutr. 2013;8(6):549-560. doi:10.1007/s12263-013-0346-6. PMID: 23737080.
Shaghaghi MA, Kloss O, Eck P. Genetic variation in human vitamin C transporter genes in common complex diseases. Adv Nutr. 2016;7(2):314-25. doi:10.3945/an.115.008516.
Tanaka T, Scheet P, Giusti B et al. Genome-wide association study of vitamin B6, vitamin B12, folate, and homocysteine blood concentrations. Am J Hum Genet. 2009;84(4):477-82. doi:10.1016/j.ajhg.2009.02.011. PMID: 19303062.
Hazra A, Kraft P, Selhub J et al. Common variants of FUT2 are associated with plasma vitamin B12 levels. Nat Genet. 2008;40(10):1160-2. PMID: 19744961.
Velkova A, Diaz JE, Pangilinan F et al. The FUT2 secretor variant p.Trp154Ter influences serum vitamin B12 concentration via holo-haptocorrin, but not holo-transcobalamin, and is associated with hematological parameters. Hum Mol Genet. 2017;26(24):4975-4988. doi:10.1093/hmg/ddx373. PMID: 29040465.
Oussalah A, Levy J, Rischer M et al. Association of TCN2 rs1801198 c.776G>C polymorphism with markers of one-carbon metabolism and related diseases: a systematic review and meta-analysis of genetic association studies. Am J Clin Nutr. 2017;106(4):1142-1156. doi:10.3945/ajcn.116.146001. PMID: 28814397.
Yuan H, Zhang Y, Li X et al. A review of the relationship between the SLC6A4 gene and mental disorders. J Transl Genet Genom. 2025;9:286-303. doi:10.20517/jtgg.2025.52.
Fratelli C, Grosso G, Chiavarini M et al. 5HTTLPR genetic variant and major depressive disorder: a review. Genes (Basel). 2020;11(11):1260. doi:10.3390/genes11111260.
Clasen PC, Wells TT, Ellis AJ, Beevers CG. Gaze-contingent music reward therapy for depression: a randomized controlled trial. Genes Brain Behav. 2011;10(7):740-6. doi:10.1111/j.1601-183X.2011.00719.x. PMID: 21745335.
Chmielowiec K, Chmielowiec J, Strzelec B et al. Associations between COMT rs4680 gene polymorphism and personality dimensions and anxiety. Genes (Basel). 2022;13(10):1768. doi:10.3390/genes13101768. PMID: 36292653.
Bachmann V, Klein C, Bodenmann S et al. The BDNF Val66Met polymorphism modulates sleep intensity: EEG frequency- and state-specificity. Sleep. 2012;35(3):335-44. doi:10.5665/sleep.1690. PMID: 22379239.
Tomasi J, Lisoway AJ, Zai CC et al. Toward a precision medicine approach to antidepressant therapy: evidence from MAOA rs6323 and BDNF rs6265 in anxiety phenotypes. J Psychiatr Res. 2020;126:1-9. doi:10.1016/j.jpsychires.2020.04.007. PMID: 32289651.
Karmakar A. MAOA rs6323 mini-review in neuropsychiatric conditions. MGM J Med Sci. 2023;10(2):148-153. PMID: 37034063.
Naoi M, Maruyama W, Shamoto-Nagai M. Type A monoamine oxidase and serotonin are coordinately involved in depressive disorder: from neurotransmitter imbalance to sleep disruption. J Neural Transm. 2018;125(1):5-20. doi:10.1007/s00702-017-1709-9.
Hettema JM, An SS, Neale MC et al. Association between glutamic acid decarboxylase genes and anxiety disorders, major depression, and neuroticism. Mol Psychiatry. 2006;11(9):847-57. doi:10.1038/sj.mp.4001845. PMID: 16314869.
Donner J, Haapakoski R, Ezer S et al. Assessment of the neuropeptide S system in anxiety disorders. Biol Psychiatry. 2010;68(5):474-83. PMID: 20452072.
Marenco S, Savostyanova AA, van der Veen JW et al. Genetic modulation of GABA levels in the anterior cingulate cortex by GAD1 and COMT. Neuropsychopharmacology. 2010;35(7):1542-51. doi:10.1038/npp.2010.23. PMID: 20130534.
Derijk R, de Kloet ER. Corticosteroid receptor polymorphisms: determinants of vulnerability and resilience. Eur J Pharmacol. 2008;583(2-3):303-11. PMID: 19047802.
Scaini S, Belotti R, Ogliari A. Genetic and environmental contributions to social anxiety across different ages: a meta-analytic approach to twin data. J Anxiety Disord. 2014;28(7):650-6. PMID: 33217702.
Kumar P, Rai V. COMT gene Val158Met polymorphism and susceptibility to obsessive compulsive disorder: a meta-analysis. Metab Brain Dis. 2020;35(2):241-251. doi:10.1007/s11011-019-00499-4. PMID: 31879835.
de Salles Andrade JB, Giori IG, Fontenelle LF, Kohlrausch FB. Serotonin transporter and glutamate transporter gene polymorphisms associated with obsessive-compulsive disorder. J Clin Neurosci. 2019;62:53-59. doi:10.1016/j.jocn.2018.12.022. PMID: 30661718.
Fujii T, Hori H, Ikenouchi-Sugita A et al. Effect of the common functional FKBP5 variant (rs1360780) on the hypothalamic-pituitary-adrenal axis and peripheral blood gene expression. Psychoneuroendocrinology. 2014;42:89-97. doi:10.1016/j.psyneuen.2014.01.001.
Richter A, Stark R, Kruse O et al. Interaction of FKBP5 variant rs3800373 and city living alters the neural stress response in the anterior cingulate cortex. Stress. 2021;24(5):646-654. doi:10.1080/10253890.2020.1864517. PMID: 33541187.
Laas K, Reif A, Akkermann K et al. Nice guys: Homozygocity for the TPH2 -703G/T (rs4570625) minor allele promotes low aggressiveness and low anxiety. J Affect Disord. 2017;208:544-548. doi:10.1016/j.jad.2016.10.025. PMID: 28342337.
Huang JH, Lai IC, Ngo ST et al. Serotonin receptor 1A promoter polymorphism, rs6295, modulates human anxiety levels via altering parasympathetic nervous activity. Acta Psychiatr Scand. 2018;138(1):68-75. doi:10.1111/acps.12880. PMID: 29363117.
Li X, Hu H, Li X et al. The rs6311 of serotonin receptor 2A (5-HT2A) gene is associated with alexithymia and mental health. J Affect Disord. 2020;274:277-283. doi:10.1016/j.jad.2020.05.068. PMID: 32553368.
Childs E, Hohoff C, Deckert J et al. Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology. 2008;33(12):2791-800. doi:10.1038/npp.2008.17. PMID: 18305461.
Babic Leko M, Hof PR, Simic G et al. Association of the MAOB rs1799836 Single Nucleotide Polymorphism and APOE epsilon4 Allele in Alzheimer’s Disease. Curr Alzheimer Res. 2021;18(3):248-258. doi:10.2174/1567205018666210512023438. PMID: 34533445.
Aronica L, Demonstrated J, Tafra M et al. Genetic biomarkers of metabolic detoxification for personalized lifestyle medicine. Nutrients. 2022;14(4):768. doi:10.3390/nu14040768.
PMC5700940. Mold sensitivity genetics paper. CYP1A1 and mycotoxin metabolism; confirmed in OAT audit.
Makowska M, Szybalska A, Lutkowska A et al. An association between the rs1799853 and rs1057910 polymorphisms of CYP2C9, the rs4244285 polymorphism of CYP2C19 and the prevalence rates of drug-resistant epilepsy in children. Int J Neurosci. 2021;131(11):1083-1089. doi:10.1080/00207454.2020.1779084. PMID: 32567426.
Chen K, Shen Z, Gu W et al. Synonymous mutation rs2515641 affects CYP2E1 mRNA and protein expression and susceptibility to drug-induced liver injury. Pharmacogenomics. 2020;21(6):379-389. doi:10.2217/pgs-2019-0163. PMID: 32149563.
Okutan G, García-Martín E, Agundez JAG, Martínez C, Ayuso P. Prevalence of genetic diamine oxidase (DAO) deficiency in female patients with fibromyalgia in Spain. Biomedicines. 2023;11(3):660. doi:10.3390/biomedicines11030660. PMID: 36979637.
Shen H, Zhang D, Hu X et al. IL-23R polymorphisms and susceptibility to ulcerative colitis: a systematic review and meta-analysis. Int J Clin Exp Pathol. 2017;10(4):4223-4233.
PMC3192060. Functional studies on IL23R implicate reduced receptor function in the protective genetic variant R381Q.
Alikhani R, Tabatabaei SM, Besharat S et al. Association between MUC1 rs4072037 polymorphism and Helicobacter pylori in patients with gastric cancer. Caspian J Intern Med. 2024;15(1):132-140. doi:10.22088/cjim.15.1.15. PMID: 38463926.
Ashton JJ, Mossotto E, Stafford IS et al. NOD2 in Crohn’s disease: unfinished business. J Crohns Colitis. 2023;17(3):450-458. doi:10.1093/ecco-jcc/jjac132. PMID: 36006803.
Hu M, Xie S, Li Y et al. Fucosyltransferase 2: a genetic risk factor for intestinal diseases. Front Microbiol. 2022;13:940196. doi:10.3389/fmicb.2022.940196. PMID: 35923409.
TReLong Study. Modulation of human longevity by SIRT3 single nucleotide polymorphisms in the prospective TRELONG study. Age (Dordr). 2013;35(5):1987-98. PMID: 23839864.
Bachmann V, Klaus F, Bodenmann S et al. Functional ADA polymorphism increases sleep depth and reduces vigilant attention in humans. Cereb Cortex. 2012;22(5):962-70. doi:10.1093/cercor/bhr173. PMID: 21734253.
Tartar JL, Ward CP, McKenna JT et al. A functional adenosine deaminase polymorphism associates with evening melatonin levels and sleep quality. J Circadian Rhythms. 2021;19:2. doi:10.5334/jcr.209. PMID: 33981350.
